Fundraising Fox

Geron

NASDAQ: GERN

2 known investors

Geron is a biopharmaceutical company focused on developing therapies for blood cancer. The company has over 30 years of experience in research and clinical development.

BiotechHealthtechLongevityMedical Devices

Investors · 2

BioBritLa Jolla
New Enterprise Associates (NEA)Menlo Park · $200K – $40M

Frequently asked questions

What does Geron do?
Geron is a biopharmaceutical company focused on developing therapies for blood cancer. The company has over 30 years of experience in research and clinical development.
Who are Geron's investors?
Geron's investors include BioBrit, New Enterprise Associates (NEA).